Therefore, NRP1 overexpression is described as a poor prognostic factor in various cancers, such as lung cancers (70), pancreatic cancers (15), liver cancers (13), breast cancers (16), gliomas (12), and medulloblastomas (14). The gene discussed is NRP1; the disease is breast cancer.